TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 56 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,160 | +333.7% | 66,190 | -9.3% | 0.00% | – |
| Q2 2023 | $48,225 | -17.1% | 72,958 | 0.0% | 0.00% | – |
| Q1 2023 | $58,191 | -64.7% | 72,958 | 0.0% | 0.00% | – |
| Q4 2022 | $164,885 | +114.1% | 72,958 | +82.7% | 0.00% | – |
| Q3 2022 | $77,000 | -46.5% | 39,927 | +2.8% | 0.00% | – |
| Q2 2022 | $144,000 | -89.3% | 38,821 | -81.1% | 0.00% | – |
| Q1 2022 | $1,340,000 | -46.5% | 205,625 | -4.3% | 0.00% | – |
| Q4 2021 | $2,504,000 | -36.5% | 214,970 | +1.4% | 0.00% | -100.0% |
| Q3 2021 | $3,946,000 | -6.4% | 211,928 | +6.6% | 0.00% | 0.0% |
| Q2 2021 | $4,216,000 | +114.2% | 198,859 | +105.2% | 0.00% | – |
| Q1 2021 | $1,968,000 | -28.2% | 96,924 | -6.1% | 0.00% | -100.0% |
| Q4 2020 | $2,740,000 | – | 103,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |